CHICAGO - The Society for Vascular Surgery® (SVS) today announced that Covidien, a leading global supplier of healthcare products, has made a significant contribution to the Society for Vascular Surgery® Foundation, the philanthropic arm of SVS. The donation supports vascular research and advances Covidien’s focus on improving patient outcomes.
“The SVS Foundation funds research that leads to advancements in the quality of care and ultimately the outcomes provided to our vascular patients,” said Robert Zwolak, MD, chair of the SVS Foundation. “Covidien shares this mission.”
The Foundation offers support to vascular surgeons along the continuum of their research career. The Foundation’s support ranges from a Multicenter Clinical Planning Grant to assisting experienced investigators develop competitive applications for external funding of full-scale multicenter clinical studies to mentored clinical and patient-oriented career development awards.
As a global healthcare products leader, Covidien is focused on helping medical professionals perform their lifesaving work. “Our Company is committed to investing in professional education and training that ultimately improves patient care,” said Brian Verrier, vice president/general manager, Vascular Therapies, Covidien. “Through this five-year grant program, we aim to help vascular surgeons and specialists - worldwide - enhance their skills with new research tools and approaches that address specific health needs.”
# # #
About the Society for Vascular Surgery®
The Society for Vascular Surgery® (SVS) is a not-for-profit professional medical society, composed primarily of vascular surgeons, that seeks to advance excellence and innovation in vascular health through education, advocacy, research, and public awareness. SVS is the national advocate for 3,750 specialty-trained vascular surgeons and other medical professionals who are dedicated to the prevention and cure of vascular disease. Visit its Web site at www.VascularWeb.org
® and follow SVS on Twitter by searching for VascularHealth or at http://twitter.com/VascularHealth